KK
GILD icon

KLP Kapitalforvaltning’s Gilead Sciences GILD Stock Holding History

KLP Kapitalforvaltning’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$100M Sell
718,408
-72,400
-9% -$10.1M 0.39% 40
2025
Q4 		$97.1M Sell
790,808
-5,500
-0.7% -$668K 0.37% 41
2025
Q3 		$88.4M Buy
796,308
+100
+0% +$11.4K 0.35% 44
2025
Q2 		$88.3M Buy
796,208
+20,100
+3% +$2.14M 0.38% 41
2025
Q1 		$87M Buy
776,108
+21,500
+3% +$2.22M 0.43% 33
2024
Q4 		$69.7M Buy
+754,608
New +$67.9M 0.33% 47

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

KLP Kapitalforvaltning's GILD Position: Q1 2026 in Review

KLP Kapitalforvaltning reduced its Gilead Sciences (GILD) stake by 9.2% in Q1 2026, selling an estimated $10.1M and leaving 718,408 shares worth $100M. The position accounts for 0.39% of the portfolio, ranked #40.

KLP Kapitalforvaltning first reported a position in GILD in Q4 2024 and has held it in 6 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • KLP Kapitalforvaltning held 718,408 shares of Gilead Sciences worth $100M as of Q1 2026.
  • KLP Kapitalforvaltning sold 72,400 Gilead Sciences shares in Q1 2026, an estimated $10.1M.
  • Gilead Sciences made up 0.39% of KLP Kapitalforvaltning's portfolio in Q1 2026, its #40 holding.
  • KLP Kapitalforvaltning first reported a position in Gilead Sciences in Q4 2024 and has held it in 6 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q1 2026, filed 29 Apr 2026.